Lucas Gutiérrez

1.1k total citations · 1 hit paper
36 papers, 829 citations indexed

About

Lucas Gutiérrez is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Lucas Gutiérrez has authored 36 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Computational Theory and Mathematics and 9 papers in Organic Chemistry. Recurrent topics in Lucas Gutiérrez's work include Computational Drug Discovery Methods (12 papers), Protein Structure and Dynamics (10 papers) and Synthesis and biological activity (4 papers). Lucas Gutiérrez is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Protein Structure and Dynamics (10 papers) and Synthesis and biological activity (4 papers). Lucas Gutiérrez collaborates with scholars based in Argentina, Spain and United States. Lucas Gutiérrez's co-authors include Ricardo D. Enriz, Meiying Luo, Tongtong Gao, Kexin Zhang, Yongfei Yang, Douglas O’Connell, Yu Li, Long‐Fei Wu, Tian Zhang and Peng Zhang and has published in prestigious journals such as Scientific Reports, Trends in Pharmacological Sciences and Cell Death and Differentiation.

In The Last Decade

Lucas Gutiérrez

34 papers receiving 821 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma

2018 371 citations Meiying Luo, Long‐Fei Wu et al. Cell Death and Differentiation profile →

Peers

Countries citing papers authored by Lucas Gutiérrez

Since Specialization

Citations

This map shows the geographic impact of Lucas Gutiérrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Gutiérrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Gutiérrez more than expected).

Fields of papers citing papers by Lucas Gutiérrez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Gutiérrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Gutiérrez. The network helps show where Lucas Gutiérrez may publish in the future.

Co-authorship network of co-authors of Lucas Gutiérrez

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Gutiérrez. A scholar is included among the top collaborators of Lucas Gutiérrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Gutiérrez. Lucas Gutiérrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluation 2024 ·RSC Medicinal Chemistry ·Lucas Gutiérrez, (unknown), (unknown), Nace Zidar, D. Kikelj, Ricardo D. Enriz	1
2	Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study 2024 ·Bioorganic & Medicinal Chemistry ·Nace Zidar, Andrej Emanuel Cotman, (unknown), Ondřej Benek, Michaela Barančoková, Anamarija Zega, Lucíja Peterlin Mašič, Tihomir Tomašič, Janez Ilaš, (unknown), (unknown), Anthony Maxwell, Clare E. M. Stevenson, David M. Lawson, Geert Jan Sterk, (unknown), Lucas Gutiérrez, Ricardo D. Enriz, D. Kikelj	2
3	Trifluoromethylcinnamanilides – Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum 2024 ·Bioorganic Chemistry ·Jiří Kos, (unknown), (unknown), Lucas Gutiérrez, (unknown), Jan Juřica, Ondřej Zendulka, (unknown), Jana Gregorová, (unknown), Tomáš Goněc, Michal Oravec, (unknown), Vladimı́r Kryštof, Alois Čížek, Pierre Francotte, Michel Frédérich, Josef Jampílek, Ricardo D. Enriz	0
4	Synthesis of Structurally Related Coumarin Derivatives as Antiproliferative Agents 2023 ·ACS Omega ·(unknown), (unknown), (unknown), Romen Carrillo, Félix Machín, (unknown), Lucas Gutiérrez, (unknown), (unknown), Mauricio Menacho-Márquez, Claudio O. Fernández, Celina Garcı́a, (unknown)	8
5	Computer-aided structure-based optimization of 4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives as DNA gyrase B inhibitors 2023 ·New Journal of Chemistry ·Lucas Gutiérrez, (unknown), (unknown), Martina Durcik, Lucíja Peterlin Mašič, Tihomir Tomašič, Ricardo D. Enriz	2
6	Epitopes mapped onto SARS-CoV-2 receptor-binding motif by five distinct human neutralising antibodies 2022 ·Molecular Simulation ·Lucas Gutiérrez, (unknown), (unknown), Ricardo D. Enriz, Héctor A. Baldoni	0
7	Structure, interface stability and hot-spots identification for RBD(SARS-CoV-2):hACE2 complex formation 2021 ·Molecular Simulation ·Sebastián A. Andújar, Lucas Gutiérrez, Ricardo D. Enriz, Héctor A. Baldoni	4
8	Strategies targeting FLT3 beyond the kinase inhibitors 2021 ·Pharmacology & Therapeutics ·(unknown), (unknown), (unknown), (unknown), Lucas Gutiérrez, (unknown), Houda Alachkar	17
9	Deciphering the TCR Repertoire to Solve the COVID-19 Mystery 2020 ·Trends in Pharmacological Sciences ·Lucas Gutiérrez, (unknown), Houda Alachkar	44
10	The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations 2020 ·Journal of Pharmaceutical Sciences ·Lucas Gutiérrez, Nina S. Cauchon, (unknown), Michael J. Giffin, (unknown)	21
11	Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Adriana Garro, Lucas Gutiérrez, Sebastián A. Andújar, Ricardo D. Enriz	25
12	Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors 2019 ·Bioorganic Chemistry ·(unknown), Daniel Insuasty, Santiago Lima, Lucas Gutiérrez, Manuel Nogueras, Antonio Marchal, Rodrigo Abonı́a, Sebastián A. Andújar, Sarah Spiegel, Justo Cobo, Ricardo D. Enriz	20
13	miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma breakdown → 2018 ·Cell Death and Differentiation ·Meiying Luo, Long‐Fei Wu, Kexin Zhang, Hong Wang, Tian Zhang, Lucas Gutiérrez, Douglas O’Connell, Peng Zhang, Yu Li, Tongtong Gao, Wenyan Ren, Yongfei Yang	371
14	Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia 2018 ·Scientific Reports ·Lucas Gutiérrez, Miran Jang, Tian Yi Zhang, Mojtaba Akhtari, Houda Alachkar	25
15	Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor 2017 ·Journal of Molecular Modeling ·(unknown), (unknown), Sebastián V. Rojas, Emilio Angelina, Sebastián A. Andújar, Lucas Gutiérrez, Nuria Cabedo, María‐Jesús Sanz, María Pilar López-Gresa, Diego Cortés, Ricardo D. Enriz	9
16	Pentameric models as alternative molecular targets for the design of new antiaggregant agents 2016 ·Current Protein and Peptide Science ·Exequiel Barrera, Lucas Gutiérrez, Sebastián A. Andújar, Emilio Angelina, Ana M. Rodrı́guez, Ricardo D. Enriz	13
17	Dopaminergic isoquinolines with hexahydrocyclopenta[ ij ]-isoquinolines as D 2 -like selective ligands 2016 ·European Journal of Medicinal Chemistry ·(unknown), Sebastián A. Andújar, (unknown), Lucas Gutiérrez, Noureddine El Aouad, María‐Jesús Sanz, Ricardo D. Enriz, Nuria Cabedo, Diego Cortés	15
18	Asymptomatic memory CD8⁺T cells 2014 ·Human Vaccines & Immunotherapeutics ·Arif A. Khan, Ruchi Srivastava, (unknown), Christine Wang, Thanh Pham, (unknown), (unknown), Lucas Gutiérrez, Lbachir BenMohamed	20
19	Structural and functional insights into the anti-BACE1 Fab fragment that recognizes the BACE1 exosite 2013 ·Journal of Biomolecular Structure and Dynamics ·Lucas Gutiérrez, Sebastián A. Andújar, Ricardo D. Enriz, Héctor A. Baldoni	7
20	Molecular Modeling Study of Dihydrofolate Reductase Inhibitors. Molecular Dynamics Simulations, Quantum Mechanical Calculations, and Experimental Corroboration 2013 ·Journal of Chemical Information and Modeling ·(unknown), Sebastián A. Andújar, Lucas Gutiérrez, Emilio Angelina, Ricaurte Rodríguez, Manuel Nogueras, Héctor A. Baldoni, Fernando D. Suvire, Justo Cobo, Ricardo D. Enriz	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact